Thrivent Financial for Lutherans
GBT

Thrivent Financial for Lutherans’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,137
Closed -$1.6M – 2501
2022
Q2 		$1.6M Sell
50,137
-3,347
-6% -$98K ﹤0.01% 1376
2022
Q1 		$1.85M Sell
53,484
-55
-0.1% -$1.64K ﹤0.01% 1376
2021
Q4 		$1.57M Buy
53,539
+272
+0.5% +$8.43K ﹤0.01% 1562
2021
Q3 		$1.36M Buy
53,267
+329
+0.6% +$9.67K ﹤0.01% 1637
2021
Q2 		$1.85M Buy
52,938
+847
+2% +$33.1K ﹤0.01% 1464
2021
Q1 		$2.12M Sell
52,091
-85,437
-62% -$3.93M ﹤0.01% 1380
2020
Q4 		$5.96M Buy
137,528
+45,380
+49% +$2.24M 0.01% 801
2020
Q3 		$5.08M Buy
92,148
+78,037
+553% +$4.96M 0.01% 788
2020
Q2 		$890K Hold
14,111
– – ﹤0.01% 1572
2020
Q1 		$720K Buy
+14,111
New +$945K ﹤0.01% 1505
2017
Q2 		– Sell
-30,400
Closed -$1.12M – 2092
2017
Q1 		$1.12M Sell
30,400
-21,070
-41% -$531K ﹤0.01% 1102
2016
Q4 		$744K Hold
51,470
– – ﹤0.01% 1302
2016
Q3 		$1.19M Hold
51,470
– – 0.01% 1065
2016
Q2 		$854K Buy
+51,470
New +$1.04M ﹤0.01% 1170

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Thrivent Financial for Lutherans's GBT Position: Q3 2022 in Review

Thrivent Financial for Lutherans sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 50,137 shares — an estimated $1.6M sold.

Thrivent Financial for Lutherans first reported a position in GBT in Q2 2016 and held it in 14 quarters. The position peaked at $5.96M in Q4 2020. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Thrivent Financial for Lutherans reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 50,137 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $1.6M.
  • Thrivent Financial for Lutherans first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 14 quarters.
  • Thrivent Financial for Lutherans's Global Blood Therapeutics, Inc. position peaked at $5.96M in Q4 2020.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2022, filed 14 Nov 2022.